Health Discovery Corporation
HDVY
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -20.07% | 109.43% | 31.40% | 63.83% | 35.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.07% | 109.43% | 31.40% | 63.83% | 22.37% |
| Operating Income | 20.07% | -109.72% | -31.40% | -63.83% | -22.37% |
| Income Before Tax | -69.15% | -218.56% | 74.82% | -139.33% | -24.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -69.15% | -218.56% | 74.82% | -139.33% | -24.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.15% | -218.56% | 74.82% | -139.33% | -24.47% |
| EBIT | 20.07% | -109.72% | -31.40% | -63.83% | -22.37% |
| EBITDA | -- | -- | -- | -36.74% | -16.89% |
| EPS Basic | -71.43% | -213.89% | 76.92% | -80.00% | 12.50% |
| Normalized Basic EPS | 25.00% | -204.35% | 81.82% | -33.33% | 20.00% |
| EPS Diluted | -71.43% | -236.67% | 76.92% | -11.11% | 30.00% |
| Normalized Diluted EPS | 25.00% | -226.32% | 81.82% | -33.33% | 20.00% |
| Average Basic Shares Outstanding | 1.04% | 2.74% | 3.96% | 33.48% | 33.91% |
| Average Diluted Shares Outstanding | 1.04% | -12.92% | 3.96% | 33.48% | 33.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
